BridgeBio Pharma Files Registration for Shelf Offering of $350 Million of Mixed Securities - (Fidelity via NewsPoints Desk)

  • BridgeBio Pharma registered with the US Securities and Exchange Commission for a shelf offering of common and preferred stock, debt securities, warrants and units worth up to $350 million, as reported Fidelity on Wednesday.

  • The company said it may use the proceeds for general corporate purposes.

To read more NewsPoints articles, click here.